Real-World Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the Action Study.

被引：0
|
作者：
Nuesslein, H. [1 ]
Alten, R. [2 ]
Galeazzi, M. [3 ]
Lorenz, H. M. [4 ]
Boumpas, Dimitrios [5 ]
Nurmohamed, M. T. [6 ]
Bensen, W. [7 ,8 ]
Burmester, G. R. [9 ]
Peter, H. -H. [10 ]
Rainer, F. [11 ]
Pavelka, Karel [12 ]
Chartier, M. [13 ]
Poncet, C. [14 ]
Rauch, C. [15 ]
Le Bars, M. [16 ]
机构：
[1] Univ Erlangen Nurnberg, Nurnberg, Germany
[2] Univ Med, Schlosspk Klin, D-13353 Berlin, Germany
[3] Univ Siena, I-53100 Siena, Italy
[4] Univ Heidelberg Hosp, Heidelberg, Germany
[5] Panepistimio Kritis, Rethimnon, Greece
[6] Vrije Univ Amsterdam Med Ctr, Jan van Bremen Res Inst, Amsterdam, Netherlands
[7] St Joseph Hosp, Hamilton, ON, Canada
[8] McMaster Univ, Hamilton, ON, Canada
[9] Charite, D-13353 Berlin, Germany
[10] Univ Med Ctr Freiburg, Freiburg, Germany
[11] Hosp Barmherzige Brueder, Graz, Austria
[12] Inst Rheumatol, Prague, Czech Republic
[13] Chiltern Int, Neuilly, France
[14] Docs Int, Sevres, France
[15] Bristol Myers Squibb Co, Munich, Germany
[16] Bristol Myers Squibb Co, Rueil Malmaison, France
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
460
引用
收藏
页码：S199 / S200
页数：2
相关论文
共 50 条
  • [1] Real-world Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis: 12-Month Interim Analysis of the ACTION Study
    Bensen, William
    Nuesslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Boumpas, Dimitrios
    Nurmohamed, Michael
    Burmester, Gerd
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Charner, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 985 - 985
  • [2] REAL-WORLD EFFICACY AND SAFETY OF ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS: 12-MONTH INTERIM ANALYSIS OF THE ACTION STUDY
    Nusslein, Hubert
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hannes M.
    Boumpas, Dimitrios
    Nurmohamed, Michael T.
    Bensen, William
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. RHEUMATOLOGY, 2013, 52 : 90 - 91
  • [3] DO PREDICTORS OF IV ABATACEPT RETENTION DEPEND ON THE LINE OF RHEUMATOID ARTHRITIS TREATMENT: 12-MONTH INTERIM ANALYSIS OF THE OBSERVATIONAL, PROSPECTIVE ACTION STUDY
    Alten, R.
    Nuesslein, H.
    Galeazzi, M.
    Lorenz, H. M.
    Mariette, X.
    Cantagrel, A.
    Chartier, M.
    Elbez, Y.
    Rauch, C.
    Le Bars, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 202 - 202
  • [4] Efficacy and Safety of Abatacept Treatment for Rheumatoid Arthritis in a Real-life Setting in European and Canadian Populations: A 6-Month Interim Analysis of the ACTION Study
    Khraishi, Majed
    Nuesslein, Hubert
    Lorenz, Hannes
    Alten, Rieke
    Bensen, William
    Bessette, Louis
    Burmester, Gerd
    Peter, Hans-Hartmut
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) : 1728 - 1728
  • [5] Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
    Nuesslein, Hubert G.
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Boumpas, Dimitrios
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [6] Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
    Hubert G Nüßlein
    Rieke Alten
    Mauro Galeazzi
    Hanns-Martin Lorenz
    Dimitrios Boumpas
    Michael T Nurmohamed
    William G Bensen
    Gerd R Burmester
    Hans-Hartmut Peter
    Franz Rainer
    Karel Pavelka
    Melanie Chartier
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. BMC Musculoskeletal Disorders, 15
  • [7] EFFICACY AND SAFETY OF ABATACEPT IN CHINESE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: REAL-WORLD DATA
    Qing, Y. F.
    Huang, Q.
    Zhao, Z. Y.
    Zhang, Q. B.
    Li, L. Q.
    Wen, Z.
    You, Z. X.
    Tang, H.
    Xu, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1291 - 1292
  • [8] Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    [J]. RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
  • [9] The Efficacy and Safety of Abatacept in SLE: Results of a 12-month Exploratory Study
    Merrill, J. T.
    Burgos-Vargas, R.
    Westhovens, R.
    Chalmers, A.
    D'Cruz, D.
    Wallace, D.
    Bae, S. C.
    Sigal, L.
    Becker, J-C
    Kelly, S.
    Raghupathi, K.
    Peng, Y.
    Kinaszczuk, M.
    Nash, P.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 4031 - 4032
  • [10] What is the Real-World Effectiveness and Safety of Golimumab in the Treatment of Rheumatoid Arthritis over a 12 Month Period?
    Bensen, William
    Kelsall, John
    Choquette, Denis
    Avina-Zubieta, Antonio
    Chow, Andrew
    Sholter, Dalton
    Fortin, Isabelle
    Sampalis, John
    Psaradellis, Eliofotisti
    Nantel, Francois
    Otawa, Susan
    Lehman, Allen
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1297 - 1297
12345